Medical Device News

Radiation Shield Technologies Offers Patented Demron Apparel Providing Healthcare Workers and First Responders Unique Anti-Coronavirus Protection

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

“The standard gear worn by healthcare workers and first responders is ineffective at preventing transmission of the Coronavirus,” said Ronald DeMeo, M.D., CEO of Radiation Shield Technologies, the surgeon who developed the technology.

Demron provides the highest protection that cannot be found anywhere else. With this deadly virus posing an increased risk to those caring for the afflicted as well as the general public, it is critical for healthcare workers and first responders to wear the latest gear offering the highest protection.”

Dr. DeMeo received global news attention in 2011 when he recognized that emergency responders in Japan lacked proper gear while working to contain the country’s worst nuclear crisis since 1945. His Miami-based company then donated Demron full-body nuclear radiation protection suits to protect power plant workers and rescue teams. Similarly, Dr. DeMeo is now issuing a call-to-action to help ensure American healthcare workers and first responders utilize the appropriate gear to minimize Coronavirus contamination risk.

In addition to face masks that provide the highest level of protection against disease transmission, the Demron suits have patented thermal conductive capabilities that enable health-care workers suits to be externally monitored for the onset of fever, one of the first signs of the disease.

Additionally, Coronavirus-infected patients can also be monitored and externally cooled when infection transportation chambers are lined with the Demron fabric. Ongoing testing in this area is being carried out by Dipl. Eng. Pavel Castulik, Ph.D., at the Research Centre for Toxic Compounds in the Environment, Masaryk University, Czech Republic.

Demron, manufactured solely by RST, is the world’s first and only CBRN fabric that provides chemical, biological, radiological, and nuclear protection, while also enabling external temperature monitoring.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

Valencia Technologies Announces CMS Publication of 2025 Medicare Proposed Rule for eCoin® Procedure

Ann Decker, VP of Reimbursement for Valencia Technologies, stated, "The cumulative effect of the proposed 2025 continuation of APC assignment 5464, the improved ASC payment rate, and the recognition of ITNS as a minimally invasive OAB treatment option in the recently updated guidelines by the American Urological Association (AUA) and the Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction (SUFU), underscores that the eCoin ITNS system will have a strong reimbursement pathway throughout 2025 and beyond.